PDS Biotechnology
PDSB
PDSB
57 hedge funds and large institutions have $141M invested in PDS Biotechnology in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $166M → $141M (-$25M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
57
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.64M | |
| 2 | +$626K | |
| 3 | +$338K | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$296K |
| 5 |
State Street
Boston,
Massachusetts
|
+$154K |
Top Sellers
| 1 | -$2.9M | |
| 2 | -$2.85M | |
| 3 | -$400K | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$335K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$230K |